CYTK

Nasdaq

CYTOKINETICS INC

Latest disclosureOctober 6, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 48 sales

Price by TradingView

Insider transactions 163

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. Sales: $8.7M by 3 insiders.

Showing the first 6 of 48 trades on this page.

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $214.83K
Reported price: $61.38 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $490.95K
Reported price: $65.46 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $239.02K
Reported price: $68.29 / share

Sale disclosed

Robert E. Landry

Director

Common Stock

Reported value: $72.13K
Reported price: $72.13 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $550.8K
Reported price: $73.44 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $6.79M
Reported price: $69.33 / share

Sale disclosed

Robert E. Landry

Director

Common Stock

Reported value: $74.66K
Reported price: $74.66 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $264.11K
Reported price: $75.46 / share

Sale disclosed

B. Lynne Parshall

Director

Common Stock

Reported value: $357.4K
Reported price: $71.48 / share

Sale disclosed

Andrew Callos

EVP, Chief Commercial Officer

Common Stock

Reported value: $702.4K
Reported price: $70.24 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $526.8K
Reported price: $70.24 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $265.37K
Reported price: $75.82 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $575.7K
Reported price: $76.76 / share

Sale disclosed

Andrew Callos

EVP, Chief Commercial Officer

Common Stock

Reported value: $1.12M
Reported price: $79.88 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $606.53K
Reported price: $80.87 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $282.07K
Reported price: $80.59 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $820.2
Reported price: $82.02 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $614.33K
Reported price: $82.02 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $303.17K
Reported price: $86.62 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $636.9K
Reported price: $84.92 / share

Sale disclosed

Andrew Callos

EVP, Chief Commercial Officer

Common Stock

Reported value: $1.29M
Reported price: $85.80 / share

Sale disclosed

Sung Lee

EVP, Chief Financial Officer

Common Stock

Reported value: $97.62K
Reported price: $87.79 / share

Sale disclosed

Sung Lee

EVP, Chief Financial Officer

Common Stock

Reported value: $3.19M
Reported price: $82.30 / share

Sale disclosed

Sung Lee

EVP, Chief Financial Officer

Common Stock

Reported value: $266.39K
Reported price: $85.00 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $278.29K
Reported price: $79.51 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $528.45K
Reported price: $70.46 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $237.93K
Reported price: $67.98 / share

Sale disclosed

Edward M. MD Kaye

Director

Common Stock

Reported value: $223.17K
Reported price: $76.09 / share

Sale disclosed

Andrew Callos

EVP, Chief Commercial Officer

Common Stock

Reported value: $1.11M
Reported price: $74.08 / share

Sale disclosed

B. Lynne Parshall

Director

Common Stock

Reported value: $370.4K
Reported price: $74.08 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $579.08K
Reported price: $77.21 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $264.92K
Reported price: $75.69 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $584.4K
Reported price: $77.92 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $270.8K
Reported price: $77.37 / share

Sale disclosed

Wendell Wierenga

Director

Common Stock

Reported value: $302.4K
Reported price: $75.00 / share

Sale disclosed

Sung Lee

EVP, Chief Financial Officer

Common Stock

Reported value: $1.84M
Reported price: $76.87 / share

Sale disclosed

John T. Henderson

Director

Common Stock

Reported value: $1.52M
Reported price: $75.97 / share

Sale disclosed

Andrew Callos

EVP, Chief Commercial Officer

Common Stock

Reported value: $875.47K
Reported price: $77.25 / share

Sale disclosed

Andrew Callos

EVP, Chief Commercial Officer

Common Stock

Reported value: $1.03M
Reported price: $65.00 / share

Sale disclosed

Andrew Callos

EVP, Chief Commercial Officer

Common Stock

Reported value: $948.9K
Reported price: $63.26 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $447.15K
Reported price: $59.62 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $229.92K
Reported price: $65.69 / share

Sale disclosed

Andrew Callos

EVP, Chief Commercial Officer

Common Stock

Reported value: $491.78K
Reported price: $66.02 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $490.35K
Reported price: $65.38 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $228.24K
Reported price: $65.21 / share

Sale disclosed

Fady Ibraham Malik

EVP Research & Development

Common Stock

Reported value: $64.75K
Reported price: $64.75 / share

Sale disclosed

Robert I. Blum

President & CEO

Common Stock

Reported value: $499.73K
Reported price: $66.63 / share

Sale disclosed

Andrew Callos

EVP, Chief Commercial Officer

Common Stock

Reported value: $236.54K
Reported price: $65.00 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
EVP Research & Development	Common StockSale10b5-1	3,500$61.38 / share	$214.83K	Oct 6Filed Oct 6 · 0d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$65.46 / share	$490.95K	Sep 28Filed Sep 28 · 0d later	SEC filing
EVP Research & Development	Common StockSale10b5-1	3,500$68.29 / share	$239.02K	Sep 22Filed Sep 22 · 0d later	SEC filing
Director	Common StockSale10b5-1	1,000$72.13 / share	$72.13K	Sep 15Filed Sep 15 · 0d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$73.44 / share	$550.8K	Sep 14Filed Sep 15 · 1d later	SEC filing
President & CEO	Common StockSale10b5-1	97,926$69.33 / share	$6.79M	Sep 15Filed Sep 15 · 0d later	SEC filing
Director	Common StockSale10b5-1	1,000$74.66 / share	$74.66K	Sep 11Filed Sep 11 · 0d later	SEC filing
EVP Research & Development	Common StockSale10b5-1	3,500$75.46 / share	$264.11K	Sep 8Filed Sep 8 · 0d later	SEC filing
Director	Common StockSale10b5-1	5,000$71.48 / share	$357.4K	Sep 1Filed Sep 1 · 0d later	SEC filing
EVP, Chief Commercial Officer	Common StockSale10b5-1	10,000$70.24 / share	$702.4K	Aug 31Filed Aug 31 · 0d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$70.24 / share	$526.8K	Aug 31Filed Aug 31 · 0d later	SEC filing
EVP Research & Development	Common StockSale10b5-1	3,500$75.82 / share	$265.37K	Aug 18Filed Aug 18 · 0d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$76.76 / share	$575.7K	Aug 10Filed Aug 10 · 0d later	SEC filing
EVP, Chief Commercial Officer	Common StockSale10b5-1	14,000$79.88 / share	$1.12M	Jul 30Filed Jul 30 · 0d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$80.87 / share	$606.53K	Jul 27Filed Jul 27 · 0d later	SEC filing
EVP Research & Development	Common StockSale10b5-1	3,500$80.59 / share	$282.07K	Jul 21Filed Jul 23 · 2d later	SEC filing
President & CEO	Common StockSale10b5-12 trades	7,500avg $82.02 / share	$615.15K	Jul 13Filed Jul 14 · 1d later	2 filings 10 @ $82.02 · $820.2SEC filing 7,490 @ $82.02 · $614.33KSEC filing
EVP Research & Development	Common StockSale10b5-1	3,500$86.62 / share	$303.17K	Jul 7Filed Jul 7 · 0d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$84.92 / share	$636.9K	Jul 1Filed Jul 2 · 1d later	SEC filing
EVP, Chief Commercial Officer	Common StockSale10b5-1	15,000$85.80 / share	$1.29M	Jul 1Filed Jul 2 · 1d later	SEC filing
EVP, Chief Financial Officer	Common StockSale10b5-1	1,112$87.79 / share	$97.62K	Jul 1Filed Jul 2 · 1d later	SEC filing
EVP, Chief Financial Officer	Common StockSale10b5-1	38,730$82.30 / share	$3.19M	Jun 24Filed Jun 29 · 5d later	SEC filing
EVP, Chief Financial Officer	Common StockSale10b5-1	3,134$85.00 / share	$266.39K	Jun 29Filed Jun 29 · 0d later	SEC filing
EVP Research & Development	Common StockSale10b5-1	3,500$79.51 / share	$278.29K	Jun 23Filed Jun 23 · 0d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$70.46 / share	$528.45K	Jun 15Filed Jun 15 · 0d later	SEC filing
EVP Research & Development	Common StockSale10b5-1	3,500$67.98 / share	$237.93K	Jun 9Filed Jun 9 · 0d later	SEC filing
Director	Common StockSale10b5-1	2,933$76.09 / share	$223.17K	Jun 1Filed Jun 1 · 0d later	SEC filing
EVP, Chief Commercial Officer	Common StockSale10b5-1	15,000$74.08 / share	$1.11M	Jun 1Filed Jun 1 · 0d later	SEC filing
Director	Common StockSale10b5-1	5,000$74.08 / share	$370.4K	Jun 1Filed Jun 1 · 0d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$77.21 / share	$579.08K	May 27Filed May 28 · 1d later	SEC filing
EVP Research & Development	Common StockSale10b5-1	3,500$75.69 / share	$264.92K	May 19Filed May 20 · 1d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$77.92 / share	$584.4K	May 14Filed May 14 · 0d later	SEC filing
EVP Research & Development	Common StockSale10b5-1	3,500$77.37 / share	$270.8K	May 5Filed May 5 · 0d later	SEC filing
Director	Common StockSale10b5-1	4,032$75.00 / share	$302.4K	May 5Filed May 5 · 0d later	SEC filing
EVP, Chief Financial Officer	Common StockSale10b5-1	23,906$76.87 / share	$1.84M	May 5Filed May 5 · 0d later	SEC filing
Director	Common StockSale10b5-1	20,000$75.97 / share	$1.52M	May 5Filed May 5 · 0d later	SEC filing
EVP, Chief Commercial Officer	Common StockSale10b5-1	11,333$77.25 / share	$875.47K	May 5Filed May 5 · 0d later	SEC filing
EVP, Chief Commercial Officer	Common StockSale10b5-1	15,857$65.00 / share	$1.03M	May 1Filed May 4 · 3d later	SEC filing
EVP, Chief Commercial Officer	Common StockSale10b5-1	15,000$63.26 / share	$948.9K	Apr 30Filed Apr 30 · 0d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$59.62 / share	$447.15K	Apr 29Filed Apr 29 · 0d later	SEC filing
EVP Research & Development	Common StockSale10b5-1	3,500$65.69 / share	$229.92K	Apr 21Filed Apr 21 · 0d later	SEC filing
EVP, Chief Commercial Officer	Common StockSale10b5-1	7,449$66.02 / share	$491.78K	Apr 15Filed Apr 15 · 0d later	SEC filing
President & CEO	Common StockSale10b5-1	7,500$65.38 / share	$490.35K	Apr 15Filed Apr 15 · 0d later	SEC filing
EVP Research & Development	Common StockSale10b5-12 trades	4,500avg $65.11 / share	$292.99K	Apr 7Filed Apr 8 · 1d later	2 filings 3,500 @ $65.21 · $228.24KSEC filing 1,000 @ $64.75 · $64.75KSEC filing
President & CEO	Common StockSale10b5-1	7,500$66.63 / share	$499.73K	Apr 1Filed Apr 1 · 0d later	SEC filing
EVP, Chief Commercial Officer	Common StockSale10b5-1	3,639$65.00 / share	$236.54K	Mar 31Filed Mar 31 · 0d later	SEC filing

Congress transactions 2

All Congress filings

Purchase disclosed

Cytokinetics, Incorporated - Common Stock (CYTK) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 30, 2026

Purchase disclosed

Cytokinetics, Incorporated - Common Stock (CYTK) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 9, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001061983
Latest public acceptance: Oct 6, 2026, 08:25 PM UTC
Score calculated: Oct 8, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

EVP Research & Development

Common StockSale10b5-1

3,500$61.38 / share

$214.83K

Oct 6Filed Oct 6 · 0d later